Concepedia

William K. Kelly

WK

35

Publications

3.5K

Citations

25

H-Index

1995

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Thomas Jefferson University

Cornell University

Sidney Kimmel Cancer Center

Yale Cancer Center

William K. Kelly is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, urology, and oncology.

ORCID

Top concepts

Publications per year

1995–2024

35

Publications

35

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

Susan Halabi, Chen‐Yen Lin, William K. Kelly et al. · Journal of Clinical Oncology · 2014 · 461 citations

Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.

John A. McCaffrey, S Hilton, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1997 · 375 citations

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.

Ronald Ghossein, Howard I. Scher, William L. Gerald et al. · Journal of Clinical Oncology · 1995 · 217 citations

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer

David B. Solit, S. Percy Ivy, Catherine Kopil et al. · Clinical Cancer Research · 2007 · 210 citations

Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer

Matthew D. Galsky, Eric J. Small, William Oh et al. · Journal of Clinical Oncology · 2005 · 190 citations

Rows per page

1–5 of 35